Health hazard evaluation report: HETA-83-085-1757, Everglades National Park, Everglades, Florida.
Authors
McConnell R; Fidler AT; Chrislip D
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 83-085-1757, 1986 Dec; :1-103
Adverse health effects from exposure to N,N-diethyl-m-toluamide (134623) (DEET), an insect repellant, in employees of Everglades National Park, Florida were investigated in response to a request from the National Park Service. Employees had expressed concern about its use, and there were anecdotal reports of confusion and abnormal sweating. Approximately 155 workers were employed and would be expected to use DEET from April through October. Initial study included a self administered questionnaire (143 employees) and urinalysis (20 employees) by high pressure liquid chromatography. Reported DEET use correlated well with urine levels. Neurobehavioral analysis showed significant correlations between DEET exposure and affective symptoms, insomnia, muscle cramps, and urinary hesitation. Neurologic symptoms and skin rashes and blisters were anecdotally reported by workers. A follow up survey for pre (March) and post (August) exposure times included questionnaires and neuroperformance testing; 77 workers participated in both time segments. Initial neurologic symptoms were not confirmed; however, impaired cognitive functioning and daytime sleepiness increased post exposure. The authors conclude that skin rashes, daytime sleepiness, and impaired cognitive function are significantly associated with DEET exposure. Since a safe alternative is not available, it is recommended that exposure be minimized by using lower concentrations and making use of protective clothing.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.